Skip to main content

Prescription pills containing oxycodone and acetaminophen are shown in this June 20, 2012, photo.

Graeme Roy/THE CANADIAN PRESS

Prescription painkillers and illicit fentanyl are together fuelling a national epidemic of opioid-related overdoses, claiming the lives of more than 2,800 people in Canada last year, new figures show.

The crisis is affecting every region, according to the first complete national snapshot of opioid-related deaths for 2016.

Canada's chief public health officer Theresa Tam said the grim statistic, unveiled on Thursday, represents an average of eight people dying every day. She said the Public Health Agency of Canada plans to deploy epidemiologists to the provinces and territories to help gain a better understanding of regional variations.

Story continues below advertisement

Read more: Opioid sellers use Internet's dark corners to stump RCMP, China

Also: Fentanyl's deadly path: How the powerful drug gets across Canada's border and into the hands of users

Investigation: A Killer High: How Canada got addicted to fentanyl

"No area of Canada is necessarily safe from this crisis," Dr. Tam told reporters at a technical briefing in Ottawa. "Everybody needs to be prepared."

Street drugs, including illicit fentanyl, accounted for a large proportion of overdose deaths in Western Canada, the region hardest-hit by the crisis, but they are not as big a problem in Atlantic Canada, Robert Strang, Nova Scotia's chief medical officer of health, said during the briefing. In Alberta, fentanyl accounted for 64 per cent of opioid-related deaths in 2016. In Nova Scotia, by contrast, 15 per cent of deaths involved fentanyl, leaving the vast majority linked to prescription painkillers, including pharmaceuticals diverted to the street.

"We are facing two different but overlapping issues: first, overdose deaths from prescription opioids and second, overdose deaths from illicit drugs laced with fentanyl or other synthetic opioids," Dr. Strang said. "There is no single solution to this crisis."

A continuing Globe and Mail investigation has found that federal and provincial governments across the country did not do enough to forestall the rise of an epidemic rooted in the overprescribing of powerful painkillers such as oxycodone, hydromorphone and fentanyl.

Story continues below advertisement

The crisis has deepened with the arrival in Canada of illicit fentanyl, a synthetic opioid that street dealers are cutting into illegal drugs, primarily heroin and cocaine.

Another measure of the toll the epidemic is taking is the number of admissions to Canadian hospitals for opioid overdoses, accidental or deliberate, which increased by 70 per cent over the past decade.

An average of 16 people a day were admitted to hospital in 2016-17, according to new figures from the Canadian Institute for Health Information (CIHI), released on Thursday. Hospitals across the country logged 5,670 admissions for inpatient care related to significant opioid poisoning in 2016-17, up from 3,344 in 2007-08. Those patients stayed in hospital for an average of 7 1/2 days. The figures do not include people treated in emergency departments and sent home.

The CIHI report also reveals that the crisis is much more than just a big-city phenomenon. Smaller cities, including Regina, London, Ont., and Moncton, were among those with the highest rates of hospitalizations owing to opioid poisoning in 2016-17, based on population.

By comparison, Toronto, the country's largest city, ranked second-lowest on a list of 34 metropolitan areas with a rate of 7.9 hospitalizations for every 100,000 population. Vancouver, a city in a province at the epicentre of the crisis, ranked in the middle of the pack with a rate of 20.5. Montreal was in last place.

Kelowna, in British Columbia's picturesque Okanagan region, had the highest rate of hospitalizations due to opioid poisoning in 2016-17. The rate was 36.3 for every 100,000 population.

Story continues below advertisement

Dr. Trevor Corneil, chief medical health officer for Interior Health, a regional health authority in British Columbia that includes the city of Kelowna, said he first identified a spike in fatal and non-fatal overdoses in late 2015. Unlike Vancouver, where much of the fentanyl problem is concentrated in the Downtown Eastside and out in the open, his research has found that many people in smaller regional cities like Kelowna tend to use drugs at home, making them more difficult to find and to treat, Dr. Corneil said in an interview. That is one reason why more people in smaller cities end up in hospital, he said.

To try to help those people using drugs at home, Interior Health began operating a mobile supervised drug-use service in April in Kelowna. The mobile unit travels to neighbourhoods that are known "hot spots" for drug use.

The challenge for policy makers across Canada will be tailoring interventions to address both prescription and illicit opioids, Dr. Strang said. Quebec Health Minister Gaétan Barrette announced on Thursday that his province will follow the example of several others and offer the opioid antidote naloxone free of charge and without a prescription in Quebec pharmacies.

Dr. Strang said more supervised drug-use sites are needed for street drug users so people can consume safely. The federal government has approved 17 new sites across Canada.

Dealing with prescription opioids is more complicated, he said, because that involves reversing two decades of overprescribing. Patients currently on high doses of prescription opioids could be at risk of turning to illicit drugs if their doctors cut them off, he said.

"We have a lot of work to do to change how opioids are prescribed," Dr. Strang said.

Report an error Editorial code of conduct
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter